dindevan 10mg tablets; phenindione 10mg tablets
mercury pharma group limited no. 1 croydon, 12-16 addiscombe road, croydon cr0 0xt, united kingdom - phenindione - tablet - phenindione 10 mg - antithrombotic agents
coumadin 1 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 1 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
coumadin 2 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolism. coumadin is indicated for the prophylaxis and/or treatment of the tromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
coumadin 2.5 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 2.5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonary embolism. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
coumadin 5 mg
taro pharmaceutical industries ltd - warfarin sodium - tablets - warfarin sodium 5 mg - warfarin - warfarin - coumadin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, and pulmonar embolis. coumadin is indicated for the prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement. coumadin is indicated to reduce the risk of death, recurrent myocardial infarction, and thromboembolic events such as stroke or systemic embolization after myocardial infarction.
warfant 1 mg tablets
mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 1 milligram(s) - vitamin k antagonists; warfarin
warfant 5 mg tablets
mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 5 milligram(s) - vitamin k antagonists; warfarin
warfant 3 mg tablets
mercury pharmaceuticals (ireland) ltd - warfarin sodium - tablet - 3 milligram(s) - vitamin k antagonists; warfarin
warfarin rosemont 1 mg/1 ml oral suspension
rosemont pharmaceuticals ltd - warfarin sodium - oral suspension - 1 milligram(s)/millilitre - vitamin k antagonists; warfarin
zepholin s.r. 200 milligram prolonged release capsules
astellas pharma co. ltd - theophylline - prolonged release capsules - 200 milligram - xanthines